At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
RenewalNail™ Plasma Treatment Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
In Brief
A clinical study evaluating RenewalNail™ Plasma Treatment System for Onychomycosis Due to Trichophyton Rubrum and Onychomycosis Due to Trichophyton Mentagrophytes. Completed, enrolled 26 participants across 2 sites.
Detailed Summary
Early feasibility study to determine if a three-treatment protocol with the RenewalNail™ plasma treatment system over a week will result in mycological cure and/or clear nail growth on the treated hallux toe.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis Due to Trichophyton Rubrum, Onychomycosis Due to Trichophyton Mentagrophytes
CountriesUnited States
CollaboratorsSymbio, LLC, Center for Dermatology Clinical Research, Inc.
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMar 2017
First PostedMar 2017
Primary CompletionApr 2018
Study CompletionJun 2018
TodayJul 2026
First PostedMar 7, 2017
Enrollment StartMar 1, 2017
Primary CompletionApr 1, 2018
Study CompletionJun 30, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.3 years ago
Interventions
RenewalNail™ Plasma Treatment Systemdevice
application of cold atmospheric plasma to a fungal infected toenail